UsAgainstAlzheimer’s Launches 2024 Brain Health Academy
16 avr. 2024 10h48 HE
|
UsAgainstAlzheimer's
WASHINGTON, April 16, 2024 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s today announced the return of its Brain Health Academy, scheduled to begin on May 9, 2024. First launched in 2022, the Academy...
Congress Passes Bills Making Major Investments in Alzheimer’s
23 mars 2024 10h15 HE
|
UsAgainstAlzheimer's
Congress passes major investments in the fight against Alzheimer’s.
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’s
08 mars 2024 07h55 HE
|
UsAgainstAlzheimer's
WASHINGTON, March 08, 2024 (GLOBE NEWSWIRE) -- The maker of donanemab, Eli Lilly, announced today that the Food and Drug Administration (FDA) will convene an advisory committee to consider the...
Organizations Unite to Improve Brain Health
08 févr. 2024 11h52 HE
|
UsAgainstAlzheimer's
Washington, DC, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Today, UsAgainstAlzheimer’s, along with collaborators AARP, GN Group, Eli Lilly, and Novo Nordisk, launched the Business Collaborative for Brain...
Alzheimer’s Leaders Discuss How to Shift Science into Clinical Practice During National Alzheimer’s Summit
20 oct. 2023 12h58 HE
|
UsAgainstAlzheimer's
Washington, DC, Oct. 20, 2023 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s this week hosted the 2023 National Alzheimer’s Summit, a groundbreaking event dedicated to applying recent scientific and...
UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi for Treatment of Early-Stage Alzheimer’s
06 juil. 2023 17h35 HE
|
UsAgainstAlzheimer's
Washington, DC, July 06, 2023 (GLOBE NEWSWIRE) -- Patient advocacy organization UsAgainstAlzheimer’s today hailed the first-of-its-kind traditional approval by the Food and Drug Administration (FDA)...
Brain Health Academy Enrollment is Now Open, First Session Launches May 17
24 avr. 2023 11h05 HE
|
UsAgainstAlzheimer's
Washington, DC, April 24, 2023 (GLOBE NEWSWIRE) -- Following the launch of its highly successful Brain Health Academy in 2022, UsAgainstAlzheimer’s today announced class will be back in session...
Sen. Collins, Rep. Eshoo Decry Medicare Coverage Rejection of Alzheimer’s Drugs
18 oct. 2022 15h12 HE
|
UsAgainstAlzheimer's
Washington, D.C., Oct. 18, 2022 (GLOBE NEWSWIRE) -- During UsAgainstAlzheimer’s 2022 National Summit, members of Congress, scientists, and other leaders spoke out against the Centers for Medicare...
TODAY: CMS Controversy, Rep. Eshoo, Nationally Recognized Scientists to Take Center Stage at UsAgainstAlzheimer’s National Summit
12 oct. 2022 12h27 HE
|
UsAgainstAlzheimer's
Washington, DC, Oct. 12, 2022 (GLOBE NEWSWIRE) -- With the federal government’s decision to deny Medicare coverage of an entire class of Alzheimer’s treatments, as well as the promising clinical...
Alzheimer's Patient Advocates Launch Free Courses Promoting Brain Health
26 mai 2022 14h37 HE
|
UsAgainstAlzheimer's
Washington, D.C., May 26, 2022 (GLOBE NEWSWIRE) -- Today UsAgainstAlzheimer’s announced the launch of The Brain Health Academy (BHA), a new series of free online courses designed in partnership with...